InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
81vette Free
08/29/24 10:51 AM
profile icon
Biggiee Free
08/16/24 8:53 AM
profile icon
Biggiee Free
08/15/24 11:31 AM
profile icon
Biggiee Free
08/14/24 2:36 PM
profile icon
Monksdream PremiumMember
04/20/24 1:22 PM
profile icon
pennypauly PremiumMember
07/31/23 10:53 AM
Bullish
Bullish
profile icon
pennypauly PremiumMember
07/31/23 9:38 AM
Bullish
Bullish
profile icon
Monksdream PremiumMember
07/28/23 8:40 AM
profile icon
TheFinalCD PremiumMember
07/28/23 8:40 AM
profile icon
Monksdream PremiumMember
07/28/23 5:53 AM
profile icon
subslover PremiumMember
07/27/23 8:44 PM
profile icon
subslover PremiumMember
07/27/23 5:08 PM
profile icon
KeepOn Free
05/22/23 10:32 PM
profile icon
buckysherm Free
04/07/23 10:12 AM
profile icon
buckysherm Free
04/07/23 10:09 AM
profile icon
axelvento Free
12/09/22 11:33 PM
profile icon
axelvento Free
11/29/22 1:33 AM
profile icon
axelvento Free
11/24/22 1:40 AM
profile icon
axelvento Free
11/21/22 12:05 AM
profile icon
axelvento Free
11/15/22 11:22 PM
profile icon
buckysherm Free
11/15/22 11:04 AM
profile icon
axelvento Free
11/07/22 11:28 PM
profile icon
axelvento Free
11/04/22 12:43 AM
profile icon
axelvento Free
11/02/22 12:14 AM
profile icon
axelvento Free
10/24/22 12:38 AM
profile icon
axelvento Free
10/20/22 12:18 AM
profile icon
axelvento Free
10/13/22 11:54 PM
profile icon
axelvento Free
10/13/22 12:16 AM
profile icon
axelvento Free
10/08/22 12:12 AM
profile icon
axelvento Free
10/06/22 1:07 AM
profile icon
Ecomike PremiumMember
10/05/22 8:17 PM
profile icon
Ecomike PremiumMember
10/05/22 8:08 PM
profile icon
axelvento Free
09/29/22 8:03 AM
profile icon
axelvento Free
09/26/22 10:32 AM
profile icon
axelvento Free
09/26/22 10:11 AM
profile icon
axelvento Free
09/26/22 9:21 AM
profile icon
axelvento Free
09/16/22 8:38 AM
profile icon
axelvento Free
09/16/22 12:00 AM

SIGA Technologies Inc (SIGA) RSS Feed

Followers
47
Posters
150
Posts (Today)
0
Posts (Total)
1366
Created
09/25/06
Type
Free
Moderators

SIGA Technologies, Inc. (Nasdaq: SIGA) is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug.


                                            
Possible complications of monkeypox include:
Broncho-pneumonia
Inflammation of brain tissue, viz., encephalitis
Infection of the cornea, the clear outer layer of the eye
Secondary infections
Sepsis (A life-threatening medical emergency, sepsis occurs when an infection you already have triggers a severe chain reaction throughout your body.)

 https://stockanalysis.com/stocks/siga/statistics/
Ownership Breakdown as of July 3, 2022

July 15, 2022
-SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics
https://investor.siga.com/news-releases/news-release-details/siga-announces-oncology-collaboration-kalivir-immunotherapeutics
July 12, 2022
-SIGA Announces Approximately US$28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
July 8, 2022

https://investor.siga.com/news-releases/news-release-details/siga-announces-approximately-28-million-international
-SIGA Technologies Receives Approval from UK for Tecovirimat (TPOXX®)
-Treatment Approved for Smallpox, Monkeypox, Cowpox, and Vaccinia Complications
https://investor.siga.com/news-releases/news-release-details/siga-technologies-receives-approval-uk-tecovirimat
June 23, 2022

-SIGA Announces US$13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
https://investor.siga.com/news-releases/news-release-details/siga-announces-13-million-international-procurement-orders-oral
May 31, 2022
-SIGA prepares to kick production for monkeypox treatment into high gear
https://www.pharmavoice.com/news/siga-monkeypox-treatment-tpoxx-dennis-hruby/624581/
May 19, 2022
-SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)
https://investor.siga.com/news-releases/news-release-details/siga-receives-approval-fda-intravenous-iv-formulation-tpoxxr
May 12, 2022
-New Contract Awarded by U.S. Department of Defense for the Procurement of Up to Approximately $7.5 Million of Oral TPOXX®
https://investor.siga.com/news-releases/news-release-details/new-contract-awarded-us-department-defense-procurement

SIGA Partners

Real time Monkeypox tracker with statistics, news, maps, graphs and cases count.
https://www.monkeypoxmeter.com/


Monkeypox Tally Information

Explore Library Monkeypox Tracker
https://twitter.com/ExploreLbry


Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. Readers are expected to conduct their own due diligence prior to the buying or the selling of any stock. All information here is for informational purposes only.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post